235 related articles for article (PubMed ID: 30126748)
1. Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice.
Hsu PY; Yen HH; Yang TH; Su CC
J Dermatol Sci; 2018 Oct; 92(1):30-37. PubMed ID: 30126748
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
Front Immunol; 2021; 12():635076. PubMed ID: 34025642
[TBL] [Abstract][Full Text] [Related]
3. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
4. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
5. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
6. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
7. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
8. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
[TBL] [Abstract][Full Text] [Related]
9. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
[TBL] [Abstract][Full Text] [Related]
10. Albendazole negatively regulates keratinocyte proliferation.
Di Fusco D; Stolfi C; Di Grazia A; Dinallo V; Laudisi F; Marafini I; Colantoni A; Monteleone I; Monteleone G
Clin Sci (Lond); 2020 Apr; 134(7):907-920. PubMed ID: 32236445
[TBL] [Abstract][Full Text] [Related]
11. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.
Zhao J; Di T; Wang Y; Wang Y; Liu X; Liang D; Li P
Eur J Pharmacol; 2016 Feb; 772():131-43. PubMed ID: 26738780
[TBL] [Abstract][Full Text] [Related]
12. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
15. The Protective Effects of 18
Chen H; Liu H; Tang B; Chen Y; Han L; Yu J; Yan Y; Lu C
J Immunol Res; 2020; 2020():1980456. PubMed ID: 32908937
[TBL] [Abstract][Full Text] [Related]
16. Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.
Kim N; Lee S; Kang J; Kwon TK; Khang D; Kim SH
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664681
[TBL] [Abstract][Full Text] [Related]
17. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
[TBL] [Abstract][Full Text] [Related]
18. IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis.
Li L; Wu Z; Wu M; Qiu X; Wu Y; Kuang Z; Wang L; Sun T; Liu Y; Yi S; Jing H; Zhou S; Chen B; Wu D; Wu W; Liu J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107008. PubMed ID: 33069927
[TBL] [Abstract][Full Text] [Related]
19. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
